DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
A telehealth service offering prescription hair-loss treatments, including compounded topicals and oral options, prescribed online after a provider review for men and women.
Musely Hair Formula Rx is worth considering if you want a single, customized prescription combining several proven hair-loss actives and you understand it is compounded rather than FDA-approved. The core actives each have solid evidence, and minoxidil-plus-DHT-blocker combination therapy beats minoxidil alone in a 2025 meta-analysis. The trade-offs are regulatory and safety-related: compounded topical 5-alpha-reductase inhibitors carry FDA-flagged systemic risks and lack standardized testing, and Musely's topical uses dutasteride, which blocks DHT more completely and lingers in the body longer than finasteride. A candid risk conversation with the prescriber is essential.
Musely Hair Formula Rx is a custom prescription that a compounding pharmacy makes after a telehealth provider reviews your photos and medical history. The topical "Hair Solution" (Classic) typically blends minoxidil 8% (widens scalp blood vessels and extends the follicle's growth phase), dutasteride (blocks both types of 5-alpha-reductase, the enzyme that creates DHT, the hormone that miniaturizes follicles in pattern hair loss), spironolactone (an additional anti-androgen), tretinoin (intended to boost minoxidil penetration), and ketoconazole plus hydrocortisone (to calm scalp inflammation and irritation). A "Modern" topical adds ingredients such as latanoprost, caffeine, and melatonin. The oral "Hair Pill" pairs low-dose oral minoxidil with dutasteride to suppress DHT systemically, and women's formulas may include spironolactone. The goal is to attack hair loss through multiple pathways at once. Note that Musely's topical uses dutasteride rather than finasteride; both block DHT, but dutasteride is more potent and has a much longer half-life.
The core actives are well-supported, though Musely's specific compounded formula has not been tested in its own published controlled trial, so efficacy is inferred from its ingredients rather than the branded product. Topical minoxidil is the only FDA-approved topical for androgenetic alopecia (oral finasteride and oral minoxidil's relatives aside, minoxidil is the topical standard): in the pivotal Olsen 2002 randomized trial of 393 men, 5% topical minoxidil produced a mean increase of about 18.6 non-vellus hairs/cm2 versus about 3.9 with placebo at 48 weeks, with roughly 60% of users rated improved on global photographic assessment versus about 23% on placebo. A 2025 systematic review and meta-analysis of 7 randomized trials (N=396) found topical minoxidil-finasteride combinations beat minoxidil alone, with a mean difference of about 9 more hairs/cm2 in density and significantly better global photographic assessment. A separate small 2025 RCT (N=40) found topical 0.1% finasteride plus 5% minoxidil performed about the same as minoxidil alone over a short 12-week window, a reminder that the added DHT-blocker benefit can take longer to show and that Musely's stronger dutasteride-based formula has not been individually validated.
Common local effects from the topical include scalp itching, dryness, flaking, redness, stinging, and a temporary increase in shedding in the first 4-12 weeks. Minoxidil can cause unwanted facial hair if it migrates and, rarely, dizziness, fluid retention, or palpitations. The serious concern is the DHT blocker: in April 2025 the FDA issued a safety alert after receiving 32 reports (2019-2024) of systemic adverse events from compounded topical finasteride, including decreased libido, erectile dysfunction, depression, anxiety, suicidal ideation, brain fog, fatigue, and insomnia, some of which persisted after stopping. Musely's topical uses dutasteride rather than finasteride, but dutasteride is a more potent, longer-acting 5-alpha-reductase inhibitor and is also absorbed through the skin, so the same class of systemic risks reasonably applies and has not been ruled out. Spironolactone can cause menstrual changes, breast tenderness, and elevated potassium. Stop and seek medical care for mood changes, suicidal thoughts, chest pain, or breathing problems.
Starts at $49/mo from Musely.
As of 2026, Musely hair treatments are out-of-pocket; insurance generally does not cover compounded cosmetic-hair prescriptions, though FSA/HSA cards may be accepted. Expect roughly $95-$155 for a multi-month (about three-month) supply depending on the formula and whether you choose auto-refill (cheaper, advertised at up to ~30% off) or a one-time purchase, plus a one-time ~$20 doctor-visit fee that covers a one-year prescription and a 60-day consultation period. Auto-refill subscriptions can be paused or canceled before shipment at no cost. Musely advertises a 60-day money-back guarantee, but it generally does not apply to prescription hair treatments (which the company states are nonrefundable), so do not count on a refund for these products. Generic 5% minoxidil bought over the counter is far cheaper if you do not need the compounded combination.
Musely Hair Formula Rx bundles legitimately effective ingredients into one custom prescription, and combining topical minoxidil with a DHT-blocking 5-alpha-reductase inhibitor does outperform minoxidil alone in published trials. But these formulas are compounded, so they skip FDA approval and standardized potency testing, and Musely's topical relies on dutasteride, a more potent, longer-acting cousin of finasteride. The FDA's 2025 alert flagged systemic side effects (including sexual and mood effects that sometimes persisted) from compounded topical finasteride, and the same systemic-absorption concern reasonably extends to topical dutasteride. Worth considering with a clinician who discusses those risks; not a casual purchase.
Its ingredients have evidence behind them: topical minoxidil is FDA-approved for hair loss and increased hair counts versus placebo in pivotal trials, and a 2025 meta-analysis of 7 randomized trials found adding a DHT-blocking 5-alpha-reductase inhibitor to minoxidil beats minoxidil alone (about 9 more hairs/cm2). Musely's specific compounded formula has not been tested in its own published trial, so results are inferred from the ingredients and vary by person; expect 3-6 months before you see changes.
No. It is a pharmacy-compounded prescription, and compounded drugs are not FDA-approved or independently tested for potency, purity, and efficacy. Minoxidil itself is FDA-approved, but topical dutasteride and topical finasteride are not, and in 2025 the FDA issued a safety alert about systemic side effects from compounded topical finasteride, a concern that reasonably extends to the dutasteride Musely uses.
The Classic topical Hair Solution typically combines minoxidil 8%, dutasteride (a DHT blocker, used instead of finasteride), spironolactone, tretinoin, ketoconazole, and hydrocortisone at compounded concentrations; a Modern version adds ingredients like latanoprost, caffeine, and melatonin. The oral Hair Pill pairs low-dose minoxidil with dutasteride, and women's formulas may add spironolactone. Exact actives and strengths are customized by the prescriber based on your case.
Common ones are scalp itching, dryness, flaking, and a temporary shedding phase in the first weeks. The serious concern is the DHT blocker: the FDA links compounded topical finasteride to systemic effects like decreased libido, erectile dysfunction, depression, anxiety, and suicidal ideation, some persisting after stopping, and Musely's more potent dutasteride is in the same drug class. Spironolactone can cause menstrual changes and raise potassium. Seek care for mood changes or chest symptoms.
As of 2026, expect roughly $95-$155 for a multi-month (about three-month) supply depending on the formula and whether you pick auto-refill or one-time pricing, plus a one-time ~$20 doctor-visit fee that covers a one-year prescription. Insurance generally does not cover it, auto-refill offers the biggest discount, and the company's money-back guarantee generally does not apply to prescription hair treatments.
Yes, Musely offers formulas for female pattern hair loss, often built around minoxidil with spironolactone and sometimes dutasteride. However, dutasteride and spironolactone are unsafe in pregnancy or breastfeeding, so women who are pregnant, nursing, or trying to conceive must avoid them and should not even handle the dutasteride-containing products; a clinician should choose the formula.
Apply the topical (a small amount) to a dry scalp in thinning areas once daily as prescribed, then wash your hands and let it dry before bed to avoid transferring it to others, which matters because of the dutasteride content. The oral pill is taken once daily. Consistency is essential, and you should always follow the exact instructions on your personalized prescription label.
Hair-loss treatments only work while you use them. Within a few months of stopping, the DHT-blocking protection and minoxidil benefit fade, and you typically lose the regrown hair and resume your prior rate of thinning. Treating pattern hair loss is a long-term commitment, not a one-time fix.
The ingredients are widely used drugs, but because the formula is compounded it is not FDA-tested for potency or safety, and the FDA's 2025 alert on topical finasteride flagged real systemic risks for this drug class, which includes the dutasteride Musely uses. It can be reasonably safe for many people under medical supervision, but you should have a frank risk discussion with the prescriber, including about mood and sexual side effects, before starting.